Natixis Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.04M Buy
15,249
+3,481
+30% +$1.73M 0.01% 686
2025
Q4
$5.73M Buy
11,768
+53
+0.5% +$24.7K 0.01% 782
2025
Q3
$4.91M Sell
11,715
-533
-4% -$179K 0.01% 842
2025
Q2
$3.52M Sell
12,248
-106,334
-90% -$31.8M 0.01% 906
2025
Q1
$36.6M Buy
118,582
+104,847
+763% +$35.9M 0.07% 285
2024
Q4
$4.85M Sell
13,735
-3,276
-19% -$1.2M 0.01% 831
2024
Q3
$6.1M Sell
17,011
-739
-4% -$250K 0.01% 778
2024
Q2
$5.65M Buy
17,750
+1,169
+7% +$309K 0.01% 757
2024
Q1
$3.81M Buy
16,581
+531
+3% +$120K 0.01% 867
2023
Q4
$3.53M Sell
16,050
-5,269
-25% -$1.21M 0.01% 854
2023
Q3
$4.82M Buy
21,319
+7,702
+57% +$1.77M 0.01% 717
2023
Q2
$3.01M Buy
13,617
+1,612
+13% +$357K 0.01% 858
2023
Q1
$2.69M Buy
+12,005
New +$2.96M 0.01% 862
2014
Q2
Sell
-6,026
Closed -$567K 1331
2014
Q1
$567K Buy
6,026
+62
+1% +$6.34K 0.01% 917
2013
Q4
$674K Buy
5,964
+126
+2% +$11.4K 0.01% 833
2013
Q3
$460K Buy
5,838
+643
+12% +$47K 0.01% 862
2013
Q2
$342K Buy
+5,195
New +$335K 0.01% 899

Other funds holding UTHR